What Is Retatrutide? Phase 3 Trials, the FDA Approval Process and Safety Warnings
What is retatrutide (GIP/GLP-1/glucagon), the triple hormone agonist developed by Eli Lilly? NEJM Phase 2 results, the TRIUMPH Phase 3 programme, where FDA approval stands and firm safety warnings.